AI flags 91% of a treatable ovarian cancer weakness from tissue images (bloomer.news)

Researchers from King’s College London have developed an AI model named HRDPath that can identify a treatable weakness in ovarian cancer by analyzing conventional tissue images rather than relying solely on genomic testing. This breakthrough has significant implications for the AI/ML community, as it demonstrates how machine learning can enhance diagnostic processes in oncology. In a study published in Nature Communications, HRDPath successfully identified about 91% of tumors with defective DNA repair machinery when evaluated across multiple images from the same patient. The model detects specific visual indicators, such as rounder cell nuclei and densely packed cancer cells, which correlate with the presence of this treatable weakness. By enabling a cost-effective and accessible testing method, HRDPath could empower clinicians to personalize treatment strategies for patients with ovarian cancer, potentially improving outcomes by targeting therapies more effectively. This innovation underlines the growing role of AI in transforming cancer diagnostics and therapy selection, addressing both efficiency and accessibility in healthcare.